MyoKardia deal is US company’s first major acquisition since Celgene last year
Home/FT/Bristol-Myers Squibb to buy heart treatment maker for $13.1bn FT Bristol-Myers Squibb to buy heart treatment maker for $13.1bn Financial Times0 Less than a minute Facebook X LinkedIn MyoKardia deal is US company’s first major acquisition since Celgene last year Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on WhatsApp (Opens in new window) WhatsApp Click to email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
